Z Feng, J Xiang, H Liu, J Li, X Xu, G Sun… - Journal of Medicinal …, 2022 - ACS Publications
Peroxisome proliferator-activator receptors α/δ (PPARα/δ) are regarded as potential
therapeutic targets for nonalcoholic steatohepatitis (NASH). However, PPARα/δ dual agonist …